Kaposi's Sarcoma after Kidney Transplantation: a 21-Years Experience
-
Dariyush Raeisi
,
Mehrdad Payandeh
,
Seyed Hamid Madani
,
Mohammad Erfan Zare
,
Atefeh Nasir Kansestani
,
Amir Hossein Hashemian
Abstract
Introduction: The long-term use of immunosuppressive agents for prevention of allograft rejection increases the risk of malignancy approximately 100 times as high as that in the general population and Kaposi’s sarcoma (KS) is a relatively common malignancy after kidney transplantation. The aim of present study was to investigate the frequency of KS in patients with kidney transplantation in 20 years period.
Material and methods: In this study Charts and pathology reports of 1487 recipients for kidney allografts treated at Imam Reza hospital between 1991 and 2012 were reviewed. The SPSS software package version 16 (SPSS Inc., Chicago, Illinois, USA) was used for the statistical analysis.
Results: There were 17 of 1487 incident cases of KS kidney transplant population at our hospital in period of study. There is no significant difference between age and gender of patients. The mean time between transplantation and non-KS malignant tumors was 34.4 ± 21.8 months (range 12–140 months), while in KS patients it was 18.7 ± 25.2 months, which was statistically significantly different (P < 0.05). After detection of KS in 12 patients, we perform serum antibody detection against HHV. Among them, 8 (66.6%) were seropositive.
Conclusion: KS is a common long-term complication in renal transplant recipients, with an increased incidence compared with the general population. Given that candidates for organ transplantation who are seropositive for HHV-8 -and thus at risk for KS- can now be identified, chemoprevention should be available in this high-risk population.
Einollahi B, Noorbala MM, Lessan Pezeshki M, et al. Incidence of post renal transplantation malignancies: a report of two centers in Tehran, Iran. Transplant Proc. 2001; 33:2812.
Nafar M, Einollahi B, Hemati K, Gholi FP, Firouzan A. Development of malignancy following living donor kidney transplantation. Transplant Proc. 2005; 37:3065-7.
Tan HH, Goh CL. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol. 2006; 7: 13–29.
Mendez JC, Paya CV. Kaposi’s sarcoma and transplantation. Herpes 2000; 7: 18–23.
Moosa MR, Treurnicht FK, van Rensberg EJ, Schneider JW, Jordaan HF, Engelbrecht S. Detection and subtyping of human herpesvirus-8 in renal transplant patients before and after remission of Kaposi’s sarcoma. Transplantation. 1998; 66:214–18.
Penn I. Kaposi’s sarcoma in transplant recipients. Transplantation. 1997; 64:669–73.
Giraldo G, Beth E, Buonaguro FM. Kaposi’s sarcoma: a natural model of interrelationships between viruses, immunologic responses, genetics, and oncogenesis. Antibiot Chemother. 1983; 32:1–11.
Haberal M, Karakayali H, Emiroglu R, Basaran O, Moray G, Bilgin N. Malignant tumors after renal transplantation. Artif Organs 2002; 26:778–81.
Qunibi W, Barri Y, Alfurayh O, Almeshari K, Khan B, Taher S, Sheth K. Kaposi’s sarcoma in renal transplant recipients: a report on 26 cases from a single institution. Transplant Proc 1993; 25:1402–5.
Marsman WA, Van Gelder T, Mulder AH, Ijzermans JN, Zietse R, Weimar W. Successful treatment of Kaposi’s sarcoma in a renal allograft recipient. Nephrol Dial Transplant 1995; 10:900–1.
Schwartz RA. Kaposi’s sarcoma. Ann Transplant 1998; 3:5–12.
Brooks JJ. Kaposi’s sarcoma: a reversible hyperplasia. Lancet 1986; 2:1309–11.
Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O'Sullivan B, Siskind V, Van Der Woude FJ, Hardie IR. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation. 1996 Mar 15; 61(5):715-21.
Mbulaiteye SM, Engels EA. Kaposi's sarcoma risk among transplant recipients in the United States (1993-2003). Int J Cancer. 2006; 119(11):2685-91.
Duman S, Toz H, Asci G, et al. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. Nephrol Dial Trans-plant. 2002; 17:892–6.
Sabeel AI, Qunibi WY, Alfurayh OA, Al-Meshari K. Kaposi’s sarcoma in Sudanese renal transplant recipients: a report from a single center. J Nephrol. 2003; 16: 412–6.
Qunibi W., Akhtar M., Sheth K. et al . (1988): Kaposi's sarcoma: the most common tumour after renal transplantation in Saudi Arabia. Am J Med; 84: 225–32.
Montagnino G., Bencini PL., Tarantino A., Caputo R., Ponticelli C. (1994): Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol; 14: 121–6.
Medveczky MM., Horvath E., Lund T., Medveczky PG. (1997): In vitro antiviral drug sensitivity of the Kaposi’s sarcoma-associated herpesvirus. AIDS; 11: 1327–32.
Neyts J., De Clercq E. (1997): Antiviral drug susceptibility of human herpesvirus 8. Antimicrob Agents Chemother; 41: 2754–6.
Robles R., Lugo D., Gee L., Jacobson MA. (1999): Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previo-usly diagnosed Kaposi’s sarcoma in patients with AIDS. AIDS Res Hum Retroviruses; 20: 34–8.
Stallone G., Schena A., Infante B. et al. (2005): Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med; 352: 1317–23.
Miller G, Rigsby M, Heston L, et al. Antibodies to butyrate-indu-cible antigens of Kaposi's sarcoma associated herpesvirus in patients with HIV-1 infection. N Engl J Med. 1996; 34: 1292–7.
Cattani P, Capuano M, Graffeo R, et al. Kaposi's sarcoma associated with previous human hepresvirus 8 infection in kidney transplant recipients. J Clin Microbiol. 2001; 39: 506–8.
Diociaiutti A, Nanni G, Cattani P, et al. HHV8 in renal transplant recipients. Transpl Int. 2000; 13 (Suppl 1): S410–S412.
Andreoni M, Goletti D, Pezzotti P, et al. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi’s sarcoma in renal and liver transplant recipients. J Infect. 2001; 43: 195–9.
Kedes DH, Ganem D. Sensitivity of Kaposi’s sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest. 1997; 99:2082-6.
| Files | ||
| Issue | Vol 7, No 4 (2013) | |
| Section | Articles | |
| Keywords | ||
| Immunosuppressive Kaposi's sarcoma Kidney transplantation | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
